FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2111693183> ?p ?o ?g. }

• W2111693183 endingPage "169" @default.
• W2111693183 startingPage "151" @default.
• W2111693183 abstract "Diabetes mellitus is a serious health problem that affects over 350 million individuals worldwide. Diabetic retinopathy (DR), which is the most common microvascular complication of diabetes, is the leading cause of new cases of blindness in working-aged adults. Diabetic macular edema (DME) is an advanced, vision-limiting complication of DR that affects nearly 30% of patients who have had diabetes for at least 20 years and is responsible for much of the vision loss due to DR. The historic standard of care for DME has been macular laser photocoagulation, which has been shown to stabilize vision and reduce the rate of further vision loss by 50%; however, macular laser leads to significant vision recovery in only 15% of treated patients. Mechanisms contributing to the microvascular damage in DR and DME include the direct toxic effects of hyperglycemia, sustained alterations in cell signaling pathways, and chronic microvascular inflammation with leukocyte-mediated injury. Chronic retinal microvascular damage results in elevation of intraocular levels of vascular endothelial growth factor A (VEGF), a potent, diffusible, endothelial-specific mitogen that mediates many important physiologic processes, including but not limited to the development and permeability of the vasculature. The identification of VEGF as an important pathophysiologic mediator of DME suggested that anti-VEGF therapy delivered to the eye might lead to improved visual outcomes in this disease. To date, four different inhibitors of VEGF, each administered by intraocular injection, have been tested in prospective, randomized phase II or phase III clinical trials in patients with DME. The results from these trials demonstrate that treatment with anti-VEGF agents results in substantially improved visual and anatomic outcomes compared with laser photocoagulation, and avoid the ocular side effects associated with laser treatment. Thus, anti-VEGF therapy has become the preferred treatment option for the management of DME in many patients." @default.
• W2111693183 created "2016-06-24" @default.
• W2111693183 creator A5004182595 @default.
• W2111693183 creator A5024052893 @default.
• W2111693183 creator A5033463159 @default.
• W2111693183 creator A5058044536 @default.
• W2111693183 date "2013-12-01" @default.
• W2111693183 modified "2023-09-30" @default.
• W2111693183 title "Anti-vascular endothelial growth factor therapy for diabetic macular edema" @default.
• W2111693183 cites W104785629 @default.
• W2111693183 cites W1481978003 @default.
• W2111693183 cites W1496977463 @default.
• W2111693183 cites W1500728559 @default.
• W2111693183 cites W1517718326 @default.
• W2111693183 cites W1526282761 @default.
• W2111693183 cites W1553961923 @default.
• W2111693183 cites W1782108791 @default.
• W2111693183 cites W1802218256 @default.
• W2111693183 cites W1971222830 @default.
• W2111693183 cites W1975028551 @default.
• W2111693183 cites W1975058097 @default.
• W2111693183 cites W1977644809 @default.
• W2111693183 cites W1980725734 @default.
• W2111693183 cites W1982179488 @default.
• W2111693183 cites W1983275470 @default.
• W2111693183 cites W1983943345 @default.
• W2111693183 cites W1987991788 @default.
• W2111693183 cites W1999957425 @default.
• W2111693183 cites W1999961827 @default.
• W2111693183 cites W2000292756 @default.
• W2111693183 cites W2001548141 @default.
• W2111693183 cites W2010599103 @default.
• W2111693183 cites W2015457963 @default.
• W2111693183 cites W2016517388 @default.
• W2111693183 cites W2020793732 @default.
• W2111693183 cites W2021149044 @default.
• W2111693183 cites W2022786677 @default.
• W2111693183 cites W2022886290 @default.
• W2111693183 cites W2023780594 @default.
• W2111693183 cites W2033204635 @default.
• W2111693183 cites W2035353185 @default.
• W2111693183 cites W2036712095 @default.
• W2111693183 cites W2037623358 @default.
• W2111693183 cites W2042225844 @default.
• W2111693183 cites W2042362462 @default.
• W2111693183 cites W2047375315 @default.
• W2111693183 cites W2049036672 @default.
• W2111693183 cites W2051869883 @default.
• W2111693183 cites W2053567993 @default.
• W2111693183 cites W2057983131 @default.
• W2111693183 cites W2058134060 @default.
• W2111693183 cites W2060148437 @default.
• W2111693183 cites W2067588222 @default.
• W2111693183 cites W2079713841 @default.
• W2111693183 cites W2084575920 @default.
• W2111693183 cites W2090115875 @default.
• W2111693183 cites W2091989599 @default.
• W2111693183 cites W2093044616 @default.
• W2111693183 cites W2093556662 @default.
• W2111693183 cites W2093924025 @default.
• W2111693183 cites W2098155102 @default.
• W2111693183 cites W2101694121 @default.
• W2111693183 cites W2104034463 @default.
• W2111693183 cites W2115756084 @default.
• W2111693183 cites W2123123877 @default.
• W2111693183 cites W2124521298 @default.
• W2111693183 cites W2137893922 @default.
• W2111693183 cites W2139634859 @default.
• W2111693183 cites W2146673937 @default.
• W2111693183 cites W2150893441 @default.
• W2111693183 cites W2156799887 @default.
• W2111693183 cites W2158029475 @default.
• W2111693183 cites W2161279821 @default.
• W2111693183 cites W2161588304 @default.
• W2111693183 cites W2164855431 @default.
• W2111693183 cites W2167049200 @default.
• W2111693183 cites W2171085327 @default.
• W2111693183 cites W2171109114 @default.
• W2111693183 cites W2337454357 @default.
• W2111693183 cites W2406931263 @default.
• W2111693183 cites W2554729258 @default.
• W2111693183 cites W2616361514 @default.
• W2111693183 cites W2726031603 @default.
• W2111693183 cites W2733537454 @default.
• W2111693183 cites W2767261857 @default.
• W2111693183 cites W2805868637 @default.
• W2111693183 cites W3198570063 @default.
• W2111693183 cites W4212945288 @default.
• W2111693183 cites W4229629337 @default.
• W2111693183 cites W4233230329 @default.
• W2111693183 cites W4233654781 @default.
• W2111693183 cites W4248932937 @default.
• W2111693183 cites W4251015126 @default.
• W2111693183 cites W4254778823 @default.
• W2111693183 cites W4293258051 @default.
• W2111693183 cites W71525847 @default.
• W2111693183 doi "https://doi.org/10.1177/2042018813512360" @default.
• W2111693183 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3855829" @default.

• next